CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndTotal current assets (Million JPY)YoY (%)
Jun 30, 20252,957+28.09%
Jun 30, 20242,308+11.65%
Jun 30, 20232,068+172.56%
Jun 30, 2022759-39.98%
Jun 30, 20211,264+2.59%
Jun 30, 20201,232+45.95%
Jun 30, 2019844+54.46%
Jun 30, 2018546-43.87%
Jun 30, 2017974+5.43%
Jun 30, 2016923-3.11%
Jun 30, 2015953+177.73%
Jun 30, 2014343
AI Chat